永顺生物
(920729)
| 流通市值：5.28亿 | | | 总市值：18.61亿 |
| 流通股本：7750.70万 | | | 总股本：2.73亿 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 38,912,067.23 | 43,556,072.4 | 19,281,429.19 | 17,323,119.52 |
| 交易性金融资产 | 13,001,830.34 | 51,063,829.96 | 50,067,094.09 | 29,822,082.19 |
| 应收票据及应收账款 | 64,178,227.89 | 68,477,893.51 | 66,424,173.37 | 82,053,407.67 |
| 其中：应收票据 | 1,379,300.9 | 1,965,939.77 | 886,852.06 | 6,491,080.5 |
| 应收账款 | 62,798,926.99 | 66,511,953.74 | 65,537,321.31 | 75,562,327.17 |
| 应收款项融资 | 224,930 | 393,872.8 | 272,740 | 1,571,837.2 |
| 预付款项 | 366,777.82 | 429,724.24 | 550,527.5 | 602,666.33 |
| 其他应收款合计 | 2,407,901.4 | 2,296,652.24 | 2,559,192.38 | 2,495,851.25 |
| 存货 | 36,979,396.64 | 38,313,026.63 | 35,017,952.09 | 32,007,701.09 |
| 一年内到期的非流动资产 | 243,150,350.67 | 64,719,795.12 | 118,981,878.45 | - |
| 其他流动资产 | 1,119,868.68 | - | - | 446,277,703.78 |
| 流动资产合计 | 400,341,350.67 | 269,250,866.9 | 293,154,987.07 | 612,154,369.03 |
| 非流动资产: | | | | |
| 其他债权投资 | 193,593,041.66 | 361,503,777.77 | 329,598,125 | - |
| 其他非流动金融资产 | 150,000 | 150,000 | 150,000 | 150,000 |
| 固定资产 | 130,486,868.86 | 137,337,825.67 | 144,333,881.76 | 151,087,804.58 |
| 在建工程 | - | - | - | 340,816.84 |
| 使用权资产 | 178,166.4 | 308,222.41 | 462,087.02 | 599,525 |
| 无形资产 | 13,112,695.68 | 13,551,408.62 | 14,458,084.02 | 15,326,203.35 |
| 长期待摊费用 | 2,978,352.36 | 3,183,216.84 | 3,388,081.32 | 2,211,587.48 |
| 递延所得税资产 | - | 474,160.13 | - | - |
| 其他非流动资产 | 8,765,800 | 8,529,700 | 8,310,270 | 9,185,246.01 |
| 非流动资产合计 | 349,264,924.96 | 525,038,311.44 | 500,700,529.12 | 178,901,183.26 |
| 资产总计 | 749,606,275.63 | 794,289,178.34 | 793,855,516.19 | 791,055,552.29 |
| 流动负债: | | | | |
| 短期借款 | 99,897.23 | 496,265.84 | - | - |
| 应付票据及应付账款 | 60,059,616.63 | 63,014,206.5 | 66,461,606.01 | 73,148,846.52 |
| 应付账款 | 60,059,616.63 | 63,014,206.5 | 66,461,606.01 | 73,148,846.52 |
| 预收款项 | - | - | - | 19,800 |
| 合同负债 | 11,365,069.19 | 13,798,124.64 | 17,859,829.96 | 21,903,560.04 |
| 应付职工薪酬 | 2,497,365.69 | 3,838,481.51 | 6,605,711.28 | 4,852,064.93 |
| 应交税费 | 1,496,108.46 | 3,255,067.88 | 1,567,767.32 | 1,637,308.36 |
| 其他应付款合计 | 11,420,030.6 | 19,412,594.02 | 17,783,095.39 | 17,877,615.14 |
| 一年内到期的非流动负债 | 195,457.93 | 349,888.11 | 502,486.08 | 611,689.51 |
| 其他流动负债 | 1,477,458.99 | 1,713,506.32 | 535,794.94 | 574,671.9 |
| 流动负债合计 | 88,611,004.72 | 105,878,134.82 | 111,316,290.98 | 120,625,556.4 |
| 非流动负债: | | | | |
| 租赁负债 | - | 9,929.16 | 9,911.6 | 50,761.44 |
| 递延收益 | 6,133,800.37 | 6,966,212.35 | 6,717,801.72 | 7,609,102.46 |
| 递延所得税负债 | 503,166.53 | - | 148,136.29 | 23,985.68 |
| 非流动负债合计 | 6,636,966.9 | 6,976,141.51 | 6,875,849.61 | 7,683,849.58 |
| 负债合计 | 95,247,971.62 | 112,854,276.33 | 118,192,140.59 | 128,309,405.98 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 273,350,000 | 273,350,000 | 273,350,000 | 273,350,000 |
| 资本公积 | 220,325,170.89 | 219,487,771.76 | 218,799,344.16 | 216,856,269.22 |
| 减:库存股 | 8,951,000 | 15,234,500 | 15,234,500 | 15,234,500 |
| 盈余公积 | 73,064,391.34 | 73,064,391.34 | 73,064,391.34 | 68,938,593.58 |
| 未分配利润 | 96,569,741.78 | 130,767,238.91 | 125,684,140.1 | 118,835,783.51 |
| 归属于母公司股东权益合计 | 654,358,304.01 | 681,434,902.01 | 675,663,375.6 | 662,746,146.31 |
| 股东权益合计 | 654,358,304.01 | 681,434,902.01 | 675,663,375.6 | 662,746,146.31 |
| 负债和股东权益合计 | 749,606,275.63 | 794,289,178.34 | 793,855,516.19 | 791,055,552.29 |
| 公告日期 | 2026-08-24 | 2026-04-28 | 2026-04-28 | 2025-10-28 |
| 审计意见(境内) | | | 标准无保留意见 | |